E2F1 and cancer: Previous studies have shown that the aggressive activity of E2F1 in cancer cells is largely dependent on the spatiotemporal availability of transcriptional coregulators that can enhance its transcriptional programs through formation of protein-protein interaction (PPI) complexes to favor the expression of genes that support a metastasis-prone TME (17–19).